Ibe R&d Institute for Lung Health Ggmbh

Ibe R&d Institute for Lung Health Ggmbh is a research organisation in Munster, Germany that has taken part in 2 EU-funded projects since 2017, receiving €393k in EU funding.

EU funding received€393k
EU projects2
As coordinator0
Running now0
First EU project2017
Latest project2022
CountryGermany
EU registration (PIC)917343163
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Ibe R&d Institute for Lung Health Ggmbh's own share of each project, not the project's full budget.

  • Horizon Europe€393k · 1 project
  • Horizon 2020€0 · 1 project

Projects

2 EU-funded projects, newest first. Each links to the official record.

  • MACRAMEPartner

    Advanced Characterisation Methodologies to assess and predict the Health and Environmental Risks of Advanced Materials

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

    €393ktheir share
  • REFINEAssociated partner

    Regulatory Science Framework for Nano(bio)material-based Medical Products and Devices

    Horizon 2020 · 2017–2022 · Project on CORDIS ↗

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • biomaterials
  • nano-materials
  • nanomedicine
  • pharmaceutical drugs
  • pharmacokinetics

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime